How The Insmed (INSM) Investment Story Is Shifting On Brinsupri And ENCORE Developments [Yahoo! Finance]
Insmed Incorporated (INSM)
Last insmed incorporated earnings: 4/30 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.insmed.com
Company Research
Source: Yahoo! Finance
Insmed's updated fair value estimate has shifted slightly, from US$214.32 to US$212.50 per share, putting fresh attention on how analysts are recalibrating their views. Recent reports around Brinsupri launch commentary, ENCORE data, and management guidance show a mix of optimism on long term growth potential and caution around valuation and execution. This blend of views is feeding directly into the latest target work. Read on to see what is driving the evolving Insmed narrative and how to follow it over time. Analyst Price Targets don't always capture the full story. Head over to our Company Report to find new ways to value Insmed. What Wall Street Has Been Saying ?? Bullish Takeaways Jefferies frames Insmed as a category defining respiratory biotech and sees Brinsupri as having a credible path to over US$8b in peak bronchiectasis sales. This supports its raised price target to US$228. BofA highlights management guidance for at least US$1b in Brinsupri sales in FY26 and de
Show less
Read more
Impact Snapshot
Event Time:
INSM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INSM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INSM alerts
High impacting Insmed Incorporated news events
Weekly update
A roundup of the hottest topics
INSM
News
- Insmed Incorporated (INSM) PT Lifted to $230 as Guggenheim Updates Biotech Earnings Models [Yahoo! Finance]Yahoo! Finance
- Insmed to Host First-Quarter 2026 Financial Results Conference Call on Thursday, May 7, 2026PR Newswire
- Insmed (INSM) had its "buy" rating reaffirmed by Roth Mkm. They now have a $212.00 price target on the stock.MarketBeat
- Insmed (INSM) had its "buy" rating reaffirmed by Guggenheim.MarketBeat
- Insmed (INSM) had its "outperform" rating reaffirmed by Royal Bank Of Canada.MarketBeat
INSM
Earnings
- 2/19/26 - Miss
INSM
Sec Filings
- 4/17/26 - Form 4
- 4/16/26 - Form 144
- 4/8/26 - Form 4
- INSM's page on the SEC website